CCL17 and atherosclerosis: The latter fits the notion that AP-1 deficiency protects against the development of atherosclerosis in hypercholesterolemic mice Thus, it is suggested that the CCL17 single-nucleotide polymorphisms rs223828 correlates with increased risk of CAD, via AP-1 activation.